Banker tracks

Jeffrey Wasserstein joined Greenhill & Co. as managing director focused on the pharmaceutical sector. He was SVP of business development and strategy at Fougera Pharmaceuticals Inc., which was acquired in July by the Sandoz Ltd. generics unit of Novartis AG (NYSE:NVS; SIX:NOVN).

Brian Markison joined Avista Capital Partners as a healthcare industry executive. He was president and CEO or Fougera Pharmaceuticals Inc. Avista has over $4 billion under management...